Clinical Evaluation of Ayurvedic Management of Asrigdara Using Menstrual Blood Loss and Hemoglobin as Outcome Measures
Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda · 01.10.2026 · 3 (4) · 97
DOI: 10.64522/v4i3.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda, online erschienen am 01.10.2026. Verfasst von Dr Shruthi M Jannu und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Asrigdara, described in Ayurveda as excessive or prolonged menstrual flow, is one of the most common gynaecological complaints in women of reproductive age and closely resembles heavy menstrual bleeding. Apart from the inconvenience it causes, repeated heavy loss steadily drains iron stores, and many women reach the clinic already anaemic, tired and breathless. Ayurvedic studies on Asrigdara have often relied on the patient’s own description of flow, which is difficult to compare from one cycle to the next. The present open-label clinical study therefore used two measurable outcomes: menstrual blood loss estimated with the Pictorial Blood Loss Assessment Chart (PBAC), and blood haemoglobin. 30 women with Asrigdara were given Pushyanuga Churna 3 g twice daily with Tandulodaka for two consecutive menstrual cycles. PBAC score, haemoglobin, duration of bleeding, number of pads used per cycle and associated symptoms were recorded before and after treatment and analysed with the paired t-test. The mean PBAC score fell from 220.0 to 95.0 (56.8% reduction), bringing the average loss below the threshold of 100 that marks heavy bleeding, and mean haemoglobin rose from 9.6 to 11.2 g/dl. Duration of bleeding came down from 8.1 to 5.6 days, pads per cycle from 18.2 to 10.4, and weakness from 2.2 to 0.8. All changes were highly significant (p < 0.001). The treatment was found effective in reducing menstrual blood loss and improving haemoglobin in Asrigdara.
Zitieren
APA
Jannu, D. S. M., Patil, D. S. S., & Veeranagoudra, D. M. V. (2026). Clinical Evaluation of Ayurvedic Management of Asrigdara Using Menstrual Blood Loss and Hemoglobin as Outcome Measures. Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda, 3(4), 97. https://doi.org/10.64522/v4i3.14
Vancouver
Jannu DSM, Patil DSS, Veeranagoudra DMV. Clinical Evaluation of Ayurvedic Management of Asrigdara Using Menstrual Blood Loss and Hemoglobin as Outcome Measures. Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda. 2026;3(4):97. doi:10.64522/v4i3.14
BibTeX
@article{Jannu2026,
author = {Jannu, Dr Shruthi M and Patil, Dr. Sujatha S. and Veeranagoudra, Dr. Madhu V},
title = {Clinical Evaluation of Ayurvedic Management of Asrigdara Using Menstrual Blood Loss and Hemoglobin as Outcome Measures},
journal = {Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda},
year = {2026},
volume = {3},
number = {4},
pages = {97},
doi = {10.64522/v4i3.14}
}
EUVIMED